Since 2011, Dr. Frank Makosiej has led the Operational Strategy & Planning Oncology group at Covance Clinical Development Services in Princeton, NJ. His group is responsible for building customized, practical and evidenced-based scenarios for partners which focus upon proactive risk identification and mitigation planning. His team leverages inputs from across Covance and Oncology Scientific Networks to enable program teams to precisely forecast and course-correct plans during study implementation. Dr. Makosiej brings several decades of clinical biopharmaceutical senior leadership experience from global companies such as Hoffman-La Roche and Organon and a clinically-oriented insight into the planning, design, and execution of large global clinical programs.